Showing 60,741 - 60,760 results of 125,024 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((mean decrease) OR (point decrease)) ))', query time: 1.47s Refine Results
  1. 60741
  2. 60742

    N‑Heterocyclic Carbenes with a <i>N</i>‑2,4-Dinitrophenyl Substituent: Comparison with PPh<sub>3</sub> and IPr by Tetsuo Sato (2010571)

    Published 2012
    “…Rh and Au complexesRhCl­(<b>2a</b>)­(cod) [<b>3a</b> (cod = 1,5-cyclooctadiene)], RhCl­(<b>2b</b>)­(cod) (<b>3b</b>), RhCl­(<b>2a</b>)­(CO)<sub>2</sub> (<b>4a</b>), RhCl­(<b>2b</b>)­(CO)<sub>2</sub> (<b>4b</b>), and AuCl­(<b>2a</b>) (<b>5a</b>)were synthesized using <b>2a</b>·HBr and <b>2b</b>·HOTf. …”
  3. 60743

    N‑Heterocyclic Carbenes with a <i>N</i>‑2,4-Dinitrophenyl Substituent: Comparison with PPh<sub>3</sub> and IPr by Tetsuo Sato (2010571)

    Published 2012
    “…Rh and Au complexesRhCl­(<b>2a</b>)­(cod) [<b>3a</b> (cod = 1,5-cyclooctadiene)], RhCl­(<b>2b</b>)­(cod) (<b>3b</b>), RhCl­(<b>2a</b>)­(CO)<sub>2</sub> (<b>4a</b>), RhCl­(<b>2b</b>)­(CO)<sub>2</sub> (<b>4b</b>), and AuCl­(<b>2a</b>) (<b>5a</b>)were synthesized using <b>2a</b>·HBr and <b>2b</b>·HOTf. …”
  4. 60744

    Table_2_Early transient dysautonomia predicts the risk of infantile epileptic spasm syndrome onset: A prospective cohort study.DOCX by Ipsita Goswami (14292725)

    Published 2022
    “…There was a trend toward decreasing CSI and DFA α1 and increasing CVI in the first 8 months of age.…”
  5. 60745

    N‑Heterocyclic Carbenes with a <i>N</i>‑2,4-Dinitrophenyl Substituent: Comparison with PPh<sub>3</sub> and IPr by Tetsuo Sato (2010571)

    Published 2012
    “…Rh and Au complexesRhCl­(<b>2a</b>)­(cod) [<b>3a</b> (cod = 1,5-cyclooctadiene)], RhCl­(<b>2b</b>)­(cod) (<b>3b</b>), RhCl­(<b>2a</b>)­(CO)<sub>2</sub> (<b>4a</b>), RhCl­(<b>2b</b>)­(CO)<sub>2</sub> (<b>4b</b>), and AuCl­(<b>2a</b>) (<b>5a</b>)were synthesized using <b>2a</b>·HBr and <b>2b</b>·HOTf. …”
  6. 60746

    Table_1_Early transient dysautonomia predicts the risk of infantile epileptic spasm syndrome onset: A prospective cohort study.DOCX by Ipsita Goswami (14292725)

    Published 2022
    “…There was a trend toward decreasing CSI and DFA α1 and increasing CVI in the first 8 months of age.…”
  7. 60747

    N‑Heterocyclic Carbenes with a <i>N</i>‑2,4-Dinitrophenyl Substituent: Comparison with PPh<sub>3</sub> and IPr by Tetsuo Sato (2010571)

    Published 2012
    “…Rh and Au complexesRhCl­(<b>2a</b>)­(cod) [<b>3a</b> (cod = 1,5-cyclooctadiene)], RhCl­(<b>2b</b>)­(cod) (<b>3b</b>), RhCl­(<b>2a</b>)­(CO)<sub>2</sub> (<b>4a</b>), RhCl­(<b>2b</b>)­(CO)<sub>2</sub> (<b>4b</b>), and AuCl­(<b>2a</b>) (<b>5a</b>)were synthesized using <b>2a</b>·HBr and <b>2b</b>·HOTf. …”
  8. 60748

    N‑Heterocyclic Carbenes with a <i>N</i>‑2,4-Dinitrophenyl Substituent: Comparison with PPh<sub>3</sub> and IPr by Tetsuo Sato (2010571)

    Published 2012
    “…Rh and Au complexesRhCl­(<b>2a</b>)­(cod) [<b>3a</b> (cod = 1,5-cyclooctadiene)], RhCl­(<b>2b</b>)­(cod) (<b>3b</b>), RhCl­(<b>2a</b>)­(CO)<sub>2</sub> (<b>4a</b>), RhCl­(<b>2b</b>)­(CO)<sub>2</sub> (<b>4b</b>), and AuCl­(<b>2a</b>) (<b>5a</b>)were synthesized using <b>2a</b>·HBr and <b>2b</b>·HOTf. …”
  9. 60749

    Data_Sheet_2_Causal relationship between non-alcoholic fatty liver disease and sarcopenia: a bidirectional Mendelian randomization study.PDF by Meng Chen (48769)

    Published 2024
    “…In the reverse MR study, weight median analysis showed that NAFLD caused a decrease in ALM (OR = 0.953, 95%CI 0.957–0.994, p = 0.001); whereas NAFLD showed no correlation with usual walking pace or grip strength (all with p > 0.05). …”
  10. 60750

    Table1_Resting-state heart rate variability after stressful events as a measure of stress tolerance among elite performers.docx by Toshiya Miyatsu (14326143)

    Published 2023
    “…HR/HRV measures correlated reliably with a change in executive function measured as a decrease in verbal fluency with exposure to a well-validated stressor. …”
  11. 60751

    Data_Sheet_1_Association Between the EAT-Lancet Diet Pattern and Risk of Type 2 Diabetes: A Prospective Cohort Study.pdf by Chenjie Xu (135659)

    Published 2022
    “…Participants who reported a one-point increase in the diet score were associated with a 6% decrease in risk of T2D (HR: 0.94, 95% CI: 0.91–0.97). …”
  12. 60752

    Data_Sheet_1_Causal relationship between non-alcoholic fatty liver disease and sarcopenia: a bidirectional Mendelian randomization study.PDF by Meng Chen (48769)

    Published 2024
    “…In the reverse MR study, weight median analysis showed that NAFLD caused a decrease in ALM (OR = 0.953, 95%CI 0.957–0.994, p = 0.001); whereas NAFLD showed no correlation with usual walking pace or grip strength (all with p > 0.05). …”
  13. 60753
  14. 60754

    DataSheet_1_Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review.pdf by Tao Ouyang (735563)

    Published 2021
    “…Hyperthyroidism (OR 3.8, 95%CI 1.7–8.6), nausea (OR 3.7, 95%CI 2.55.3), diarrhea (OR 2.7, 95%CI 2.2–3.2), colitis (OR 3.4, 95%CI 2.7–4.3), ALT increase (OR 4.9, 95%CI 3.9–6.1), AST increase (OR 3.8, 95%CI 3.0–4.9), pruritus (OR 2.4, 95%CI 1.5–3.9), rash (OR 2.8, 95%CI 2.1–3.8), fatigue (OR 2.8, 95%CI 2.2–3.7), decreased appetite (OR 2.4, 95%CI 1.5–3.8), and hypophysitis (OR 2.0, 95%CI 1.2–3.3) were more frequent with combined ICIs. …”
  15. 60755

    Table_1_Causal effects of systemic inflammatory regulators on chronic kidney diseases and renal function: a bidirectional Mendelian randomization study.xlsx by Hongdian Li (13896276)

    Published 2023
    “…In contrast, genetic susceptibility to CKD was associated with an increase in GROa, and a decrease in eGFR may lead to an increase in stem cell factor. …”
  16. 60756
  17. 60757
  18. 60758
  19. 60759
  20. 60760